Regeneron (NASDAQ: REGN) reported Q1 EPS of $10.09, $0.53 better than the analyst estimate of $9.56. Revenue for the quarter came in at $3.16 billion versus the consensus estimate of $3 billion.

For earnings history and earnings-related data on Regeneron (REGN) click here.